Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Clements

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Opinion in Rheumatology|November 1, 1995
Measuring disease activity and severity in sclerodermaP J Clements
Current Rheumatology Reports|December 21, 2000
Penicillamine in the treatment of systemic sclerosisP J Clements
Bailliere'S Best Practice & Research. Clinical Rheumatology|July 6, 2000
Systemic sclerosis (scleroderma) and related disorders: clinical aspectsP J Clements
Current Opinion in Rheumatology|November 1, 1994
Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromesP J Clements
Current Opinion in Rheumatology|November 1, 1993
Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromesP J Clements
Clinical and Experimental Immunology|November 1, 1978
Receptors for IgG (Fc receptors) on human lymphocytes: re-evaluation by multiple techniquesP J Clements, J Levy
Clinical Immunology and Immunopathology|January 1, 1977
Relative cell sizes of lymphocyte subpopulations: the effect of immunosuppressive treatmentP J Clements, J Levy
Seminars in Arthritis and Rheumatism|May 1, 1986
Cytotoxic drugs: their clinical application to the rheumatic diseasesP J Clements, J Davis
The Journal of Rheumatology. Supplement|May 1, 1997
Hypothesis for the pathogenesis of systemic sclerosisD E Furst, P J Clements
Clinics in Dermatology|April 1, 1994
Heart involvement in systemic sclerosisP J Clements, D E Furst
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Opinion in Rheumatology|November 1, 1995
Measuring disease activity and severity in sclerodermaP J Clements
Current Rheumatology Reports|December 21, 2000
Penicillamine in the treatment of systemic sclerosisP J Clements
Bailliere'S Best Practice & Research. Clinical Rheumatology|July 6, 2000
Systemic sclerosis (scleroderma) and related disorders: clinical aspectsP J Clements
Current Opinion in Rheumatology|November 1, 1994
Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromesP J Clements
Current Opinion in Rheumatology|November 1, 1993
Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromesP J Clements
Clinical and Experimental Immunology|November 1, 1978
Receptors for IgG (Fc receptors) on human lymphocytes: re-evaluation by multiple techniquesP J Clements, J Levy
Clinical Immunology and Immunopathology|January 1, 1977
Relative cell sizes of lymphocyte subpopulations: the effect of immunosuppressive treatmentP J Clements, J Levy
Seminars in Arthritis and Rheumatism|May 1, 1986
Cytotoxic drugs: their clinical application to the rheumatic diseasesP J Clements, J Davis
The Journal of Rheumatology. Supplement|May 1, 1997
Hypothesis for the pathogenesis of systemic sclerosisD E Furst, P J Clements
Clinics in Dermatology|April 1, 1994
Heart involvement in systemic sclerosisP J Clements, D E Furst
Pageof 10